Prostate Specific Antigen News and Research

RSS
MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

Medicare could save nearly $500 million per year by reducing use of low-value preventive care services

Medicare could save nearly $500 million per year by reducing use of low-value preventive care services

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

New initiative aims to increase prostate cancer screening in African Americans men

New initiative aims to increase prostate cancer screening in African Americans men

New urine test could avoid unnecessary prostate cancer biopsies

New urine test could avoid unnecessary prostate cancer biopsies

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer

HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer

New technique can rapidly diagnose prostate cancer from urine

New technique can rapidly diagnose prostate cancer from urine

Mediterranean diet has the potential to effect progression of prostate cancer

Mediterranean diet has the potential to effect progression of prostate cancer

Genetic risk score can be used to determine risk of developing prostate cancer

Genetic risk score can be used to determine risk of developing prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

New staging system can inform treatment decisions for non-metastatic prostate cancer

New staging system can inform treatment decisions for non-metastatic prostate cancer

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

Developing a blood test for prostate cancer

Developing a blood test for prostate cancer